ArticleLiver cancer2026

Real-World Evidence from a Nationwide Prospective Study of the Efficacy/Safety of Systemic Therapy for Unresectable Hepatocellular Carcinoma: First 1,000 Patients of the PRISM Study.

Masafumi Ikeda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.